Back
Genmab AS Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
17
GNMSF
Genmab AS
Last Price:
202.48
Seasonality Move:
-0.77%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNMSF is experiencing selling pressure, which indicates risk of future bearish movement.
Genmab AS Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 215.66 | Sell |
| 20-day SMA: | 221.05 | Sell |
| 50-day SMA: | 233.37 | Sell |
| 200-day SMA: | 267.15 | Sell |
| 8-day EMA: | 212.26 | Sell |
| 20-day EMA: | 219.79 | Sell |
| 50-day EMA: | 232.09 | Sell |
| 200-day EMA: | 266.24 | Sell |
Genmab AS Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.08 | Sell |
| Relative Strength Index (14 RSI): | 35.52 | Sell |
| Chaikin Money Flow: | -365 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (213.7 - 229.94) | Sell |
| Bollinger Bands (100): | (228.63 - 270.99) | Sell |
Genmab AS Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Genmab AS Stock
Is Genmab AS Stock a Buy?
- Genmab AS share price is 202.48 while GNMSF 8-day simple moving average is 215.66, which is a Sell signal.
- The stock price of GNMSF is 202.48 while Genmab AS 20-day SMA is 221.05, which makes it a Sell.
- Genmab AS 50-day simple moving average is 233.37 while GNMSF share price is 202.48, making it a Sell technically.
- GNMSF stock price is 202.48 and Genmab AS 200-day simple moving average is 267.15, creating a Sell signal.
GNMSF Technical Analysis vs Fundamental Analysis
Genmab AS Stock Info
Market Cap:
12.86B
Price in USD:
202.48
Share Volume:
552
Genmab AS 52-Week Range
52-Week High:
334.33
52-Week Low:
201.93
Sell
17
Genmab AS (GNMSF)
is a Sell
Genmab AS Share Price Forecast
-
What is the Genmab AS stock price today?
The Genmab AS stock price is 202.48 USD today. -
Will GNMSF stock go up or go down?
Genmab AS> share price is forecast to RISE/FALL based on technical indicators -
Is Genmab AS overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Genmab AS is overvalued.
Is Genmab AS Stock a Buy?
- Genmab AS share price is 202.48 while GNMSF 8-day exponential moving average is 212.26, which is a Sell signal.
- The stock price of GNMSF is 202.48 while Genmab AS 20-day EMA is 219.79, which makes it a Sell.
- Genmab AS 50-day exponential moving average is 232.09 while GNMSF share price is 202.48, making it a Sell technically.
- GNMSF stock price is 202.48 and Genmab AS 200-day simple moving average is 266.24, creating a Sell signal.
Technical Analysis of Genmab AS
Should I short Genmab AS stock?
- GNMSF Moving Average Covergence Divergence (MACD) indicator is -7.08, suggesting Genmab AS is a Sell
- Genmab AS Relative Strength Index (RSI) is 35.52, which suggest Genmab AS is oversold
- The Bollinger Bands (25) for Genmab AS is (213.7 - 229.94), which suggest Genmab AS is a Sell
- The Bollinger Bands (100) for Genmab AS is (228.63 - 270.99), which suggest Genmab AS is a Sell
* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.